BlackRock’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.88M | Buy |
|
|||||
|
2025
Q2 | $4.99M | Buy |
|
|||||
|
2025
Q1 | $652K | Buy |
|
|||||
|
2024
Q4 | $422K | Buy |
|
|||||
|
2024
Q3 | $182K | Sell |
|
|||||
|
2024
Q2 | $390K | Sell |
|
|||||
|
2024
Q1 | $4.17M | Sell |
|
|||||
|
2023
Q4 | $6.15M | Buy |
|
|||||
|
2023
Q3 | $5.27M | Buy |
|
|||||
|
2023
Q2 | $5.28M | Buy |
|
|||||
|
2023
Q1 | $244K | Buy |
|
|||||
|
2022
Q4 | $140K | Buy |
|
|||||
|
2022
Q3 | $103K | Sell |
|
|||||
|
2022
Q2 | $111K | Sell |
|
|||||
|
2022
Q1 | $116K | Sell |
|
|||||
|
2021
Q4 | $95K | Sell |
|
|||||
|
2021
Q3 | $159K | Sell |
|
|||||
|
2021
Q2 | $234K | Buy |
|
|||||
|
2021
Q1 | $6K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $24K | Hold |
|
|||||
|
2020
Q2 | $24K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $55K | Hold |
|
|||||
|
2017
Q2 | $79K | Sell |
|
|||||
|
2017
Q1 | $139K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $604K | Hold |
|
|||||
|
2014
Q4 | $625K | Hold |
|
|||||
|
2014
Q3 | $822K | Sell |
|
|||||
|
2014
Q2 | $1.34M | Hold |
|
|||||
|
2014
Q1 | $1.68M | Hold |
|
|||||
|
2013
Q4 | $1.43M | Buy |
|